SHANGHAI – Sotio AS, of Prague, has expanded its China footprint with the opening of a GMP, clean-room lab for the production of active cellular immunotherapy treatments against cancer diseases. This is their second facility, giving them a combined lab space of 1,000 square meters in Beijing. Sotio will produce therapeutic cellular treatments for patients with prostate and lung cancer.